Predictors of Refractoriness and Survival following Transarterial Chemoembolization for Hepatocellular Carcinoma: Outcomes from a Southeast Asian Cohort
Purpose Patients with hepatocellular carcinoma (HCC) become refractory to repeated sessions of transarterial chemoembolization (TACE). The aim of this study was to identify predictors associated with overall survival and refractoriness following repetitive TACE of HCC among patients in So...
Main Authors: | Rudolf V. Kuhn, Glenn Marc G. Ignacio, Jade D. Jamias, Catherine S.C. Teh |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical Publishers, Inc.
2023-12-01
|
Series: | Journal of Clinical Interventional Radiology ISVIR |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1756647 |
Similar Items
-
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2020-08-01) -
Frailty as a Predictor of Complications and Transplant-Free Survival after Transarterial Chemoembolization of Hepatocellular Carcinoma
by: Rana Rabei, et al.
Published: (2023-04-01) -
Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Guoliang Shao, et al.
Published: (2022-10-01) -
Transarterial chemoembolization with 125I seed insertion for multifocal hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2024-04-01) -
Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma
by: Xuhua Duan, et al.
Published: (2022-01-01)